<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875765/" ref="ordinalpos=1420&amp;ncbi_uid=5685050&amp;link_uid=PMC3875765" image-link="/pmc/articles/PMC3875765/figure/F7/" class="imagepopup">Figure 7. A proposed model for PDGF-D <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in HCC GR EMT-type cells.  From: Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">HCC GR cells acquired EMT phenotype where PDGF-D was up-regulated, leading to enhanced migration, invasion, and metastasis.</div></div>